SEC Info - Acelrx Pharmaceuticals Inc. - ‘8-K’ for 3/30/21

SEC Info℠

Home

Help

Please Sign In

Acelrx Pharmaceuticals Inc. – ‘8-K’ for 3/30/21 – ‘XML’

On: Wednesday, 3/31/21, at 5:09pm ET · For: 3/30/21 · Accession #: 1437749-21-7874 · File #: 1-35068

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/31/21  Acelrx Pharmaceuticals Inc.       8-K:5,9     3/30/21   12:184K                                   RDG Filings/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     25K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     14K 
 8: R1          Document And Entity Information                     HTML     46K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- acrx20210330_8k_htm                 XML     13K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.DEF  XBRL Definitions -- acrx-20210330_def                XML     37K 
 5: EX-101.LAB  XBRL Labels -- acrx-20210330_lab                     XML     48K 
 6: EX-101.PRE  XBRL Presentations -- acrx-20210330_pre              XML     36K 
 3: EX-101.SCH  XBRL Schema -- acrx-20210330                         XSD     14K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
12: ZIP         XBRL Zipped Folder -- 0001437749-21-007874-xbrl      Zip     14K

‘XML’ — XBRL Instance — acrx20210330_8k_htm

This Document is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:schemaRef xlink:href="acrx-20210330.xsd" xlink:type="simple"/>

</entity>

</period>

</context>

<dei:AmendmentFlag contextRef="d20218K"> false </dei:AmendmentFlag>

<dei:EntityCentralIndexKey contextRef="d20218K"> 0001427925 </dei:EntityCentralIndexKey>

<dei:DocumentType contextRef="d20218K"> 8-K </dei:DocumentType>

<dei:DocumentPeriodEndDate contextRef="d20218K"> 2021-03-30 </dei:DocumentPeriodEndDate>

<dei:EntityRegistrantName contextRef="d20218K"> ACELRX PHARMACEUTICALS, INC. </dei:EntityRegistrantName>

<dei:EntityIncorporationStateCountryCode contextRef="d20218K"> DE </dei:EntityIncorporationStateCountryCode>

<dei:EntityFileNumber contextRef="d20218K"> 001-35068 </dei:EntityFileNumber>

<dei:EntityTaxIdentificationNumber contextRef="d20218K"> 41-2193603 </dei:EntityTaxIdentificationNumber>

<dei:EntityAddressAddressLine1 contextRef="d20218K"> 351 Galveston Drive </dei:EntityAddressAddressLine1>

<dei:EntityAddressCityOrTown contextRef="d20218K"> Redwood City </dei:EntityAddressCityOrTown>

<dei:EntityAddressStateOrProvince contextRef="d20218K"> CA </dei:EntityAddressStateOrProvince>

<dei:EntityAddressPostalZipCode contextRef="d20218K"> 94063 </dei:EntityAddressPostalZipCode>

<dei:CityAreaCode contextRef="d20218K"> 650 </dei:CityAreaCode>

<dei:LocalPhoneNumber contextRef="d20218K"> 216-3500 </dei:LocalPhoneNumber>

<dei:WrittenCommunications contextRef="d20218K"> false </dei:WrittenCommunications>

<dei:SolicitingMaterial contextRef="d20218K"> false </dei:SolicitingMaterial>

<dei:PreCommencementTenderOffer contextRef="d20218K"> false </dei:PreCommencementTenderOffer>

<dei:PreCommencementIssuerTenderOffer contextRef="d20218K"> false </dei:PreCommencementIssuerTenderOffer>

<dei:Security12bTitle contextRef="d20218K"> Common Stock </dei:Security12bTitle>

<dei:TradingSymbol contextRef="d20218K"> ACRX </dei:TradingSymbol>

<dei:SecurityExchangeName contextRef="d20218K"> NASDAQ </dei:SecurityExchangeName>

<dei:EntityEmergingGrowthCompany contextRef="d20218K"> false </dei:EntityEmergingGrowthCompany>

</xbrl>

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/15/21  Acelrx Pharmaceuticals Inc.       424B5                  1:461K                                   RDG Filings/FA
 8/18/21  Acelrx Pharmaceuticals Inc.       S-8         8/18/21    3:97K                                    RDG Filings/FA

↑Top

Filing Submission 0001437749-21-007874 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Acelrx Pharmaceuticals Inc. – ‘8-K’ for 3/30/21 – ‘XML’

On: Wednesday, 3/31/21, at 5:09pm ET · For: 3/30/21 · Accession #: 1437749-21-7874 · File #: 1-35068

Previous ‘8-K’: ‘8-K’ on 3/30/21 for 3/26/21 · Next: ‘8-K’ on 4/27/21 for 4/21/21 · Latest: ‘8-K’ on / for 4/19/24 · 2 References: By: Talphera, Inc. – ‘424B5’ on 11/15/21 By: Talphera, Inc. – ‘S-8’ on 8/18/21

Current Report — Form 8-KFiling Table of Contents

‘XML’ — XBRL Instance — acrx20210330_8k_htm

This Document is an XBRL XML File.

2 Subsequent Filings that Reference this Filing

Previous ‘8-K’: ‘8-K’ on 3/30/21 for 3/26/21 · Next: ‘8-K’ on 4/27/21 for 4/21/21 · Latest: ‘8-K’ on / for 4/19/24 · 2 References:

Current Report — Form 8-K
Filing Table of Contents